Impact of hepatitis B birth dose on immune response in Pakistani children: an open-label, non-inferiority randomized controlled trial, implications for achieving SDG target,Infectious Diseases

当前位置： X-MOL 学术 › Infect. Dis. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Impact of hepatitis B birth dose on immune response in Pakistani children: an open-label, non-inferiority randomized controlled trial, implications for achieving SDG target
Infectious Diseases ( IF 5.8 ) Pub Date : 2023-09-15 , DOI: 10.1080/23744235.2023.2258208
Zulfikar Ali Gorar ₁ , Zahid Ahmad Butt ₂

Affiliation

Despite presence of hyperendemic areas, the national immunisation schedule in Pakistan does not include a hepatitis B birth dose, placing newborns at an additional risk of acquiring hepatitis B. Th...

中文翻译：